These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34732855)

  • 1. Estimating patient health in prostate cancer treatment counseling.
    Chesnut GT; Tin AL; Fleshner KA; Benfante NE; Vickers AJ; Eastham JA; Sjoberg DD; Carlsson SV
    Prostate Cancer Prostatic Dis; 2023 Jun; 26(2):271-275. PubMed ID: 34732855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limitations of the National Comprehensive Cancer Network
    Daskivich TJ; Wood LN; Skarecky D; Ahlering T; Freedland S
    J Urol; 2017 Feb; 197(2):356-362. PubMed ID: 27582436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Life Expectancy in Men Diagnosed with Prostate Cancer.
    Sammon JD; Abdollah F; D'Amico A; Gettman M; Haese A; Suardi N; Vickers A; Trinh QD
    Eur Urol; 2015 Nov; 68(5):756-65. PubMed ID: 25819724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the Use of Prostate Biopsy Among Men with Limited Life Expectancy in a Statewide Quality Improvement Collaborative.
    Abdollah F; Ye Z; Miller DC; Linsell SM; Montie JE; Peabody JO; Ghani KR;
    Eur Urol; 2016 Nov; 70(5):854-861. PubMed ID: 27113032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful external validation of a model to predict other cause mortality in localized prostate cancer.
    Kent M; Penson DF; Albertsen PC; Goodman M; Hamilton AS; Stanford JL; Stroup AM; Ehdaie B; Scardino PT; Vickers AJ
    BMC Med; 2016 Feb; 14():25. PubMed ID: 26860993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer.
    Walz J; Gallina A; Hutterer G; Perrotte P; Shariat SF; Graefen M; McCormack M; Bénard F; Valiquette L; Saad F; Karakiewicz PI
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):88-94. PubMed ID: 17446004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External Validation of the Prostate Cancer Specific Comorbidity Index: A Claims Based Tool for the Prediction of Life Expectancy in Men with Prostate Cancer.
    Daskivich TJ; Thomas IC; Luu M; Shelton JB; Makarov DV; Skolarus TA; Leppert JT
    J Urol; 2019 Sep; 202(3):518-524. PubMed ID: 31009286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbidity and age cannot explain variation in life expectancy associated with treatment of non-metastatic prostate cancer.
    Boehm K; Dell'Oglio P; Tian Z; Capitanio U; Chun FKH; Tilki D; Haferkamp A; Saad F; Montorsi F; Graefen M; Karakiewicz PI
    World J Urol; 2017 Jul; 35(7):1031-1036. PubMed ID: 27796538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.
    Bratt O; Folkvaljon Y; Hjälm Eriksson M; Akre O; Carlsson S; Drevin L; Franck Lissbrant I; Makarov D; Loeb S; Stattin P
    Eur Urol; 2015 Jul; 68(1):53-8. PubMed ID: 25813688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method for using life tables to estimate lifetime risk for prostate cancer death.
    Kim HL; Puymon MR; Qin M; Guru K; Mohler JL
    J Natl Compr Canc Netw; 2010 Feb; 8(2):148-54. PubMed ID: 20141675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer.
    Walz J; Gallina A; Perrotte P; Jeldres C; Trinh QD; Hutterer GC; Traumann M; Ramirez A; Shariat SF; McCormack M; Perreault JP; Bénard F; Valiquette L; Saad F; Karakiewicz PI
    BJU Int; 2007 Dec; 100(6):1254-8. PubMed ID: 17979925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Race/Ethnicity may be an Important Predictor of Life Expectancy in Localized Prostate Cancer Patients: Novel Analyses Using Social Security Administration Life Tables.
    Würnschimmel C; Nocera L; Wenzel M; Ruvolo CC; Tian Z; Saad F; Briganti A; Shariat SF; Mirone V; Chun FKH; Tilki D; Graefen M; Karakiewicz PI
    J Racial Ethn Health Disparities; 2023 Apr; 10(2):708-717. PubMed ID: 35182370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a clinical prediction model to calculate patient life expectancy: the measure of actuarial life expectancy (MALE).
    Clarke MG; Kennedy KP; MacDonagh RP
    Med Decis Making; 2009; 29(2):239-46. PubMed ID: 19047762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implementation of quality of life instruments and prediction tools for localized prostate cancer: results from a national survey of radiation oncologists and urologists.
    Kim SP; Karnes RJ; Nguyen PL; Ziegenfuss JY; Han LC; Thompson RH; Trinh QD; Sun M; Boorjian SA; Beebe TJ; Tilburt JC
    J Urol; 2013 Jun; 189(6):2092-8. PubMed ID: 23219546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ten-year rule revisited: accuracy of clinicians' estimates of life expectancy in patients with localized prostate cancer.
    Krahn MD; Bremner KE; Asaria J; Alibhai SM; Nam R; Tomlinson G; Jewett MA; Warde P; Naglie G
    Urology; 2002 Aug; 60(2):258-63. PubMed ID: 12137823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of life expectancy on cost-effectiveness of treatment options for clinically localized prostate cancer.
    Naser-Tavakolian A; Venkataramana A; Spiegel B; Almario C; Kokorowski P; Freedland SJ; Anger JT; Leppert JT; Daskivich TJ
    Urol Oncol; 2023 Apr; 41(4):205.e1-205.e10. PubMed ID: 36737259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in Communication of Competing Risks of Mortality in Prostate Cancer Treatment Consultations.
    Daskivich TJ; Gale R; Luu M; Naser-Tavakolian A; Venkataramana A; Khodyakov D; Anger JT; Posadas E; Sandler H; Spiegel B; Freedland SJ
    J Urol; 2022 Aug; 208(2):301-308. PubMed ID: 35377775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of life tables in predicting overall survival in patients after radical prostatectomy.
    Walz J; Suardi N; Shariat SF; Jeldres C; Perrotte P; Graefen M; Widmer H; Arjane P; Valiquette L; Hutterer G; Saad F; Karakiewicz PI
    BJU Int; 2008 Jul; 102(1):33-8. PubMed ID: 18384631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do older men benefit from curative therapy of localized prostate cancer?
    Alibhai SM; Naglie G; Nam R; Trachtenberg J; Krahn MD
    J Clin Oncol; 2003 Sep; 21(17):3318-27. PubMed ID: 12947068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term overall survival of radical prostatectomy patients is often superior to the general population: A comparison using life-table data.
    Würnschimmel C; Wenzel M; Wang N; Tian Z; Karakiewicz PI; Graefen M; Huland H; Tilki D
    Prostate; 2021 Aug; 81(11):785-793. PubMed ID: 34101879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.